Nelson, Christopher P
,
Goel, Anuj http://orcid.org/0000-0003-2307-4021
Butterworth, Adam S
Kanoni, Stavroula
Webb, Tom R
Marouli, Eirini
Zeng, Lingyao
Ntalla, Ioanna
Lai, Florence Y
Hopewell, Jemma C
Giannakopoulou, Olga
Jiang, Tao
Hamby, Stephen E
Di Angelantonio, Emanuele
Assimes, Themistocles L
Bottinger, Erwin P
Chambers, John C
Clarke, Robert
Palmer, Colin N A http://orcid.org/0000-0002-6415-6560
Cubbon, Richard M
Ellinor, Patrick http://orcid.org/0000-0002-2067-0533
Ermel, Raili http://orcid.org/0000-0002-2726-2364
Evangelou, Evangelos http://orcid.org/0000-0002-5488-2999
Franks, Paul W
Grace, Christopher
Gu, Dongfeng
Hingorani, Aroon D
Howson, Joanna M M
Ingelsson, Erik
Kastrati, Adnan
Kessler, Thorsten
Kyriakou, Theodosios
Lehtimäki, Terho
Lu, Xiangfeng
Lu, Yingchang
März, Winfried
McPherson, Ruth
Metspalu, Andres
Pujades-Rodriguez, Mar
Ruusalepp, Arno
Schadt, Eric E
Schmidt, Amand F
Sweeting, Michael J
Zalloua, Pierre A http://orcid.org/0000-0002-8494-5081
AlGhalayini, Kamal
Keavney, Bernard D http://orcid.org/0000-0001-9573-0812
Kooner, Jaspal S
Loos, Ruth J F
Patel, Riyaz S
Rutter, Martin K
Tomaszewski, Maciej
Tzoulaki, Ioanna http://orcid.org/0000-0002-4275-9328
Zeggini, Eleftheria http://orcid.org/0000-0003-4238-659X
Erdmann, Jeanette
Dedoussis, George
Björkegren, Johan L M
Schunkert, Heribert
Farrall, Martin
Danesh, John
Samani, Nilesh J
Watkins, Hugh
Deloukas, Panos http://orcid.org/0000-0001-9251-070X
,
,
Article History
Received: 9 February 2017
Accepted: 15 June 2017
First Online: 17 July 2017
Competing interests
: P.W.F. has been a paid consultant for Eli Lilly and Sanofi Aventis and has received research support from several pharmaceutical companies as part of a European Union Innovative Medicines Initiative (IMI) project. E.I. is an advisor and consultant for Precision Wellness, Inc., and an advisor for Cellink for work unrelated to the present project. M.K.R. has acted as a consultant for GSK, Roche, Ascensia and MSD and participated in advisory board meetings on their behalf. M.K.R. has received lecture fees from MSD and grant support from Novo Nordisk, MSD and GSK. J.L.M.B. is the founder and chairman of Clinical Gene Networks. CGN has financially contributed to the STARNET study. J.L.M.B., E.E.S. and A.R. are on the board of directors for CGN. J.L.M.B. and A.R. own equity in CGN and receive financial compensation from CGN.